Form D — LIPELLA PHARMACEUTICALS INC.
0001753926-25-000060 · filed Jan 7, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $6,000,000
- Reported amount sold
- $2,597,500
- Minimum investment
- $50,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- LIPELLA PHARMACEUTICALS INC.
- CIK
- 1347242
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 7800 SUSQUEHANNA ST.
PITTSBURGH, Pennsylvania 15208 - Phone
- (412) 894-1853
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jonathan Kaufman · Executive OfficerPittsburgh, Pennsylvania Find on LinkedIn ↗
-
Michael Chancellor · Executive OfficerPittsburgh, Pennsylvania Find on LinkedIn ↗
-
Douglas Johnston · Executive OfficerPittsburgh, Pennsylvania Find on LinkedIn ↗
-
Lori Birder · DirectorPittsburgh, Pennsylvania Find on LinkedIn ↗
-
Ryan Pruchnic · DirectorPittsburgh, Pennsylvania Find on LinkedIn ↗
-
Daniel Cohen · DirectorPittsburgh, Pennsylvania Find on LinkedIn ↗
-
Byong Kim · DirectorPittsburgh, Pennsylvania Find on LinkedIn ↗
-
Naoki Yoshimura · DirectorPittsburgh, Pennsylvania Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗